| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |